Dobi Á, Kelemen G, Kaizer L, Weiczner R, Thurzó L, Kahán Z.
Breast cancer under 40 years of age: increasing number and worse prognosis.
Pathol Oncol Res. 2011 17:425-8.
Maráz A, Furák J, Pálföldi R, Eller J, Szántó E, Kahán Z, Thurzó L, Molnár J, Tiszlavicz L, Hideghéty K.
Roles of BCL-2 and MDR1 expression in the efficacy of paclitaxel-based lung cancer chemoradiation.
Anticancer Res. 2011 31:1431-6.
Varga Z, Cserháti A, Kelemen G, Boda K, Thurzó L, Kahán Z.
Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients.
Int J Radiat Oncol Biol Phys. 2011 80:1109-16.
Nikolényi A, Sükösd F, Kaizer L, Csörgo E, Vörös A, Uhercsák G, Ormándi K, Lázár G, Thurzó L, Brodowicz T, Kahán Z.
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Oncology. 2011 80:269-77.
Horváth Z, Torday L, Hitre E, Ganofszky E, Juhos E, Czeglédi F, Urbán L, Polgár C, Láng I, Eckhardt S, Kásler M.
Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological response.
Pathol Oncol Res. 2011 3:541-50.
Maráz A. Novelties in the treatment for advanced renal-cell cancer.
Orv Hetil. 2011 17:655-62.
Lőcsei Z, Hideghéty K, Farkas R, Bellyei S, Sárosi V, Sebestyén K, Sebestyén Z, Kovács P, Mangel L.
The use of PET/CT in radiotherapy of patients with non-small cell lung cancer.
Magy Onkol. 2011 4:274-80.
Kovács P, Sebestyén Z, Farkas R, Bellyei S, Szigeti A, Liposits G, Hideghéty K, Dérczy K, Mangel L.
A pelvic phantom for modeling internal organ motions.
Med Dosim. 2011 3:250-4.
Wolfárd A, Paszt A, Szentpáli K, Hideghéthy K, Uhercsák G, Németh I, Tiszlavicz L, Lázár G.
Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus.
Hepatogastroenterology. 2011 109:1214-9.
